(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.
The three biggest winners today are Methes Energies International Ltd, SmileDirectClub, and Globalstar.
| Rank | Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|---|
| 1 | Methes Energies International Ltd (MEIL) | 0.07 | 16% | 2023-02-27 20:23:20 |
| 2 | SmileDirectClub (SDC) | 0.60 | 12.7% | 2023-02-28 15:34:04 |
| 3 | Globalstar (GSAT) | 1.28 | 10.34% | 2023-02-28 15:52:43 |
| 4 | Coinbase (COIN) | 64.96 | 10.18% | 2023-02-28 15:53:15 |
| 5 | Marinus Pharmaceuticals (MRNS) | 6.97 | 8.83% | 2023-02-28 01:09:19 |
| 6 | MediWound Ltd. (MDWD) | 12.70 | 6.9% | 2023-02-27 19:49:17 |
| 7 | Novavax (NVAX) | 9.26 | 6.75% | 2023-02-28 15:59:20 |
| 8 | United States Steel (X) | 30.67 | 6.07% | 2023-02-28 15:51:51 |
| 9 | U.S. Gold Corp (USAU) | 4.20 | 5.93% | 2023-02-28 15:49:53 |
| 10 | MEI Pharma (MEIP) | 0.22 | 5.81% | 2023-02-27 21:06:09 |
The three biggest losers today are Norwegian Cruise Line, MIND Technology, and Atrion.
| Rank | Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|---|
| 1 | Norwegian Cruise Line (NCLH) | 14.86 | -9.94% | 2023-02-28 15:59:03 |
| 2 | MIND Technology (MIND) | 0.53 | -9.49% | 2023-02-27 22:41:16 |
| 3 | Atrion (ATRI) | 594.15 | -8.96% | 2023-02-28 12:54:23 |
| 4 | Magic Software Enterprises Ltd. (MGIC) | 13.59 | -7.36% | 2023-02-27 21:12:12 |
| 5 | Kosmos Energy (KOS) | 7.93 | -7.31% | 2023-02-28 15:32:30 |
| 6 | Nektar Therapeutics (NKTR) | 1.39 | -6.71% | 2023-02-28 03:47:15 |
| 7 | DISH Network (DISH) | 11.39 | -6.68% | 2023-02-28 15:55:44 |
| 8 | Nymox Pharmaceutical Corporation (NYMX) | 0.37 | -6.58% | 2023-02-28 07:17:09 |
| 9 | Peoples Financial Corporation (PFBX) | 14.25 | -6.56% | 2023-02-28 15:15:09 |
| 10 | DouYu (DOYU) | 1.24 | -6.06% | 2023-02-28 15:32:37 |
Winners today
1. Methes Energies International Ltd (MEIL) – 16%
Methes Energies International Ltd., a renewable energy company, produces and sells biodiesel fuel and biodiesel processing equipment in the United States and Canada. It offers Denami biodiesel processors. The company also produces glycerin and offer services related to the production of biodiesel, as well as purchases and sells feedstock. It sells its products and services to a network of biodiesel fuel producers. The company was founded in 2004 and is headquartered in Las Vegas, Nevada.
NASDAQ ended the session with Methes Energies International Ltd jumping 16% to $0.07 on Tuesday, after two successive sessions in a row of gains. NASDAQ fell 0.1% to $11,455.54, after two successive sessions in a row of losses, on what was a somewhat bearish trend exchanging session today.
Earnings Per Share
As for profitability, Methes Energies International Ltd has a trailing twelve months EPS of $-0.236.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -61.54%.
Moving Average
Methes Energies International Ltd’s worth is way higher than its 50-day moving average of $0.04 and way higher than its 200-day moving average of $0.04.
Revenue Growth
Year-on-year quarterly revenue growth declined by 75.8%, now sitting on 3.72M for the twelve trailing months.
Volume
Today’s last reported volume for Methes Energies International Ltd is 5869 which is 95.07% below its average volume of 119243.
Yearly Top and Bottom Value
Methes Energies International Ltd’s stock is valued at $0.07 at 16:32 EST, way under its 52-week high of $0.10 and way above its 52-week low of $0.01.
More news about Methes Energies International Ltd.
2. SmileDirectClub (SDC) – 12.7%
SmileDirectClub, Inc., an oral care company, offers clear aligner therapy treatment. The company manages the end-to-end process, which include marketing, aligner manufacturing, fulfillment, treatment by a doctor, and monitoring through completion of their treatment with a network of approximately 250 licensed orthodontists and general dentists through its teledentistry platform, SmileCheck in the United States, Puerto Rico, Canada, Australia, the United Kingdom, New Zealand, Ireland, Hong Kong, Germany, Singapore, France, Spain, and Austria. It also offers aligners, impression and whitening kits, whitening gels, and retainers; and toothbrushes, toothpastes, water flossers, SmileSpa, and various ancillary oral care products. The company was founded in 2014 and is headquartered in Nashville, Tennessee.
NASDAQ ended the session with SmileDirectClub rising 12.7% to $0.60 on Tuesday while NASDAQ slid 0.1% to $11,455.54.
Earnings Per Share
As for profitability, SmileDirectClub has a trailing twelve months EPS of $-2.334.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 16% and 26.3%, respectively.
Volume
Today’s last reported volume for SmileDirectClub is 2804330 which is 1.01% below its average volume of 2833080.
More news about SmileDirectClub.
3. Globalstar (GSAT) – 10.34%
Globalstar, Inc. provides mobile satellite services worldwide. The company offers duplex two-way voice and data products, including mobile voice and data satellite communications services and equipment for remote business continuity, recreational usage, safety, emergency preparedness and response, and other applications; fixed voice and data satellite communications services and equipment at industrial, commercial, and residential sites, as well as rural villages and ships; and data modem services and equipment. It also provides SPOT consumer retail products, such as SPOT satellite GPS messenger for personal tracking, emergency location, and messaging solutions; and SPOT Trace, an anti-theft and asset tracking device. In addition, the company offers commercial Internet of Things one-way transmission products to track cargo containers and rail cars, as well as to monitor utility meters, and oil and gas assets. Further, it sells wholesale minutes to independent gateway operators (IGOs); and provides engineering services, such as hardware and software designs to develop specific applications; and installation of gateways and antennas. The company distributes its products directly, as well as through independent agents, dealers and resellers, retailers, IGOs, and sales force and e-commerce Website. As of December 31, 2020, it had approximately 745,000 subscribers. The company primarily serves recreation and personal, government, public safety and disaster relief, oil and gas, maritime and fishing, construction, utilities, and transportation, as well as natural resources, mining, and forestry markets. Globalstar, Inc. has a strategic alliance with XCOM Labs to jointly commercialize XCOM's capacity-multiplying technology with Globalstar's Band n53 for 5G deployments in the United States and other countries where Globalstar has terrestrial rights. The company was founded in 1993 and is headquartered in Covington, Louisiana.
NYSE ended the session with Globalstar jumping 10.34% to $1.28 on Tuesday while NYSE dropped 0.24% to $15,456.35.
Earnings Per Share
As for profitability, Globalstar has a trailing twelve months EPS of $-0.07.
More news about Globalstar.
4. Coinbase (COIN) – 10.18%
Coinbase Global, Inc. provides financial infrastructure and technology for the cryptoeconomy in the United States and internationally. The company offers the primary financial account in the cryptoeconomy for retailers; a marketplace with a pool of liquidity for transacting in crypto assets for institutions; and technology and services that enable ecosystem partners to build crypto-based applications and securely accept crypto assets as payment. Coinbase Global, Inc. was founded in 2012 and is based in Wilmington, Delaware.
NASDAQ ended the session with Coinbase rising 10.18% to $64.96 on Tuesday, after four consecutive sessions in a row of losses. NASDAQ slid 0.1% to $11,455.54, after two successive sessions in a row of losses, on what was a somewhat bearish trend trading session today.
Earnings Per Share
As for profitability, Coinbase has a trailing twelve months EPS of $13.29.
PE Ratio
Coinbase has a trailing twelve months price to earnings ratio of 4.89. Meaning, the purchaser of the share is investing $4.89 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 91.66%.
Moving Average
Coinbase’s worth is way under its 50-day moving average of $107.90 and way under its 200-day moving average of $210.61.
Sales Growth
Coinbase’s sales growth for the current quarter is negative 30.6%.
More news about Coinbase.
5. Marinus Pharmaceuticals (MRNS) – 8.83%
Marinus Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on developing and commercializing therapeutics to treat rare seizure disorders. Its clinical stage product candidate, ganaxolone, is an allosteric modulator of GABAA, developed in formulations for two routes, including intravenous (IV) and oral for adult and pediatric patient populations in acute and chronic care, and in-patient and self-administered settings. The company's ganaxolone product candidate, acts at synaptic and extrasynaptic GABAA receptors, a target for its anti-seizure, antidepressant, and anxiolytic potential. It is developing ganaxolone for status epilepticus, cyclin dependent kinase like 5 deficiency disorder, PCDH19-related epilepsy, tuberous sclerosis complex, and postpartum depression. Marinus Pharmaceuticals, Inc. has license agreement with Purdue Neuroscience Company and CyDex Pharmaceuticals, Inc. The company was incorporated in 2003 and is headquartered in Radnor, Pennsylvania.
NASDAQ ended the session with Marinus Pharmaceuticals rising 8.83% to $6.97 on Tuesday while NASDAQ slid 0.1% to $11,455.54.
Earnings Per Share
As for profitability, Marinus Pharmaceuticals has a trailing twelve months EPS of $-0.38.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -17.21%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 76.9%, now sitting on 19.84M for the twelve trailing months.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Marinus Pharmaceuticals’s EBITDA is 2.98.
Sales Growth
Marinus Pharmaceuticals’s sales growth is 252% for the current quarter and negative 49.7% for the next.
More news about Marinus Pharmaceuticals.
6. MediWound Ltd. (MDWD) – 6.9%
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx, which has completed Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds; MWPC005, a topically applied biological drug candidate that is in Phase I/II clinical trial for the treatment of non-melanoma skin cancers; and MWPC003 for connective tissue disorders. MediWound Ltd. was founded in 2000 and is headquartered in Yavne, Israel.
NASDAQ ended the session with MediWound Ltd. rising 6.9% to $12.70 on Tuesday, after three sequential sessions in a row of gains. NASDAQ dropped 0.1% to $11,455.54, after two consecutive sessions in a row of losses, on what was a somewhat negative trend exchanging session today.
Earnings Per Share
As for profitability, MediWound Ltd. has a trailing twelve months EPS of $-0.34.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -3904.67%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 43.8% and 85.7%, respectively.
Sales Growth
MediWound Ltd.’s sales growth is 20.3% for the ongoing quarter and 80.8% for the next.
More news about MediWound Ltd..
7. Novavax (NVAX) – 6.75%
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical trial; and ResVax, a respiratory syncytial virus (RSV) fusion (F) protein nanoparticle vaccine candidate. It is also developing RSV F vaccine that is in Phase II clinical trial for older adults (60 years and older), as well as that is in Phase I clinical trial for pediatrics. It has a collaboration agreement with Takeda Pharmaceutical Company Limited for the development, manufacturing, and commercialization of NVX-CoV2373, a COVID-19 vaccine candidate. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
NASDAQ ended the session with Novavax jumping 6.75% to $9.26 on Tuesday, after five successive sessions in a row of losses. NASDAQ slid 0.1% to $11,455.54, after two successive sessions in a row of losses, on what was a somewhat down trend exchanging session today.
Earnings Per Share
As for profitability, Novavax has a trailing twelve months EPS of $-7.27.
Volume
Today’s last reported volume for Novavax is 6573320 which is 6.91% below its average volume of 7061610.
More news about Novavax.
8. United States Steel (X) – 6.07%
United States Steel Corporation produces and sells flat-rolled and tubular steel products primarily in North America and Europe. It operates through four segments: North American Flat-Rolled (Flat-Rolled), Mini Mill, U. S. Steel Europe (USSE), and Tubular Products (Tubular). The Flat-Rolled segment offers slabs, strip mill plates, sheets, and tin mill products, as well as iron ore and coke. This segment serves customers in the service center, conversion, transportation, automotive, construction, container, appliance, and electrical markets. The Mini Mill segment provides hot-rolled, cold-rolled, and coated sheets and electrical products. This segment serves customers in the automotive, appliance, construction, container, transportation, and service center markets. The USSE segment provides slabs, strip mill plates, sheets, tin mill products, and spiral welded pipes. This segment serves customers in the construction, container, appliance and electrical, service center, conversion, oil, gas, and petrochemical markets. The Tubular segment offers seamless and electric resistance welded steel casing and tubing products, as well as standard and line pipe and mechanical tubing products primarily to customers in the oil, gas, and petrochemical markets. The company also engages in the real estate business. United States Steel Corporation was founded in 1901 and is headquartered in Pittsburgh, Pennsylvania.
NYSE ended the session with United States Steel jumping 6.07% to $30.67 on Tuesday, after two successive sessions in a row of gains. NYSE fell 0.24% to $15,456.35, after two successive sessions in a row of losses, on what was a somewhat bearish trend exchanging session today.
Earnings Per Share
As for profitability, United States Steel has a trailing twelve months EPS of $-3.15.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 60.75%.
Moving Average
United States Steel’s worth is way higher than its 50-day moving average of $22.37 and way above its 200-day moving average of $25.20.
Sales Growth
United States Steel’s sales growth is 28.7% for the present quarter and negative 3.7% for the next.
Revenue Growth
Year-on-year quarterly revenue growth grew by 25.2%, now sitting on 23.11B for the twelve trailing months.
Volatility
United States Steel’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.08%, a negative 0.12%, and a positive 2.09%.
United States Steel’s highest amplitude of average volatility was 0.20% (last week), 1.87% (last month), and 2.09% (last quarter).
More news about United States Steel.
9. U.S. Gold Corp (USAU) – 5.93%
U.S. Gold Corp. engages in the exploration and development of gold and precious metals in the United States. It also explores for copper and silver deposits. The company holds 100% interests in the CK Gold project, which consists of various mining leases and other mineral rights covering approximately 1,120 acres in Laramie County, Wyoming; the Keystone project that consists of 650 unpatented lode mining claims covering approximately 20 square miles in Eureka County, Nevada; and the Challis Gold project, which consists of 87 unpatented lode mining claims covering approximately 1,710 acres in Lemhi County, Idaho. It also has earn-in agreement to acquire a 50% ownership interest in the Maggie Creek project that consists of 103 unpatented mining claims covering approximately 3 square miles in Eureka County, Nevada. The company is based in Elko, Nevada.
NASDAQ ended the session with U.S. Gold Corp jumping 5.93% to $4.20 on Tuesday while NASDAQ slid 0.1% to $11,455.54.
Earnings Per Share
As for profitability, U.S. Gold Corp has a trailing twelve months EPS of $-4.367.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -45.57%.
Volatility
U.S. Gold Corp’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.41%, a negative 1.05%, and a positive 2.39%.
U.S. Gold Corp’s highest amplitude of average volatility was 1.41% (last week), 2.61% (last month), and 2.39% (last quarter).
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, U.S. Gold Corp’s stock is considered to be overbought (>=80).
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter is a negative 1500% and positive 59% for the next.
Volume
Today’s last reported volume for U.S. Gold Corp is 12652 which is 42.54% below its average volume of 22021.
More news about U.S. Gold Corp.
10. MEI Pharma (MEIP) – 5.81%
MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase II clinical trial for the treatment of patients with relapsed/refractory follicular lymphoma, as well as in Phase Ib multi-arm trial to treat B-cell malignancies; and Voruciclib, an oral cyclin-dependent kinase inhibitor, which is in Phase Ib clinical trial for acute myeloid leukemia and B-cell malignancies. It also develops ME-344, a mitochondrial inhibitor targeting the oxidative phosphorylation complex that is in Phase I clinical trial for the treatment of human epidermal growth factor receptor 2 negative breast cancer; and Pracinostat, an oral available histone deacetylase inhibitor, which is in Phase II clinical trial to treat patients with myelodysplastic syndrome. The company has a license, development, and commercialization agreement with Kyowa Kirin Company; a clinical collaboration with BeiGene, Ltd.; a license, development, manufacturing, and commercialization agreement with Helsinn Healthcare SA; and license agreements with Presage Biosciences, Inc. and CyDex Pharmaceuticals, Inc. The company was formerly known as Marshall Edwards, Inc. and changed its name to MEI Pharma, Inc. in July 2012. MEI Pharma, Inc. was founded in 2000 and is headquartered in San Diego, California.
NASDAQ ended the session with MEI Pharma rising 5.81% to $0.22 on Tuesday, following the last session’s upward trend. NASDAQ dropped 0.1% to $11,455.54, after two successive sessions in a row of losses, on what was a somewhat bearish trend exchanging session today.
Earnings Per Share
As for profitability, MEI Pharma has a trailing twelve months EPS of $-0.24.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -51.2%.
Yearly Top and Bottom Value
MEI Pharma’s stock is valued at $0.22 at 16:32 EST, way under its 52-week high of $2.20 and above its 52-week low of $0.20.
Earnings Before Interest, Taxes, Depreciation, and Amortization
MEI Pharma’s EBITDA is -1.14.
Moving Average
MEI Pharma’s worth is way below its 50-day moving average of $0.29 and way under its 200-day moving average of $0.42.
More news about MEI Pharma.
Losers Today
1. Norwegian Cruise Line (NCLH) – -9.94%
Norwegian Cruise Line Holdings Ltd., together with its subsidiaries, operates as a cruise company in North America, Europe, the Asia-Pacific, and internationally. The company operates the Norwegian Cruise Line, Oceania Cruises, and Regent Seven Seas Cruises brands. It offers itineraries ranging from three days to a 180-days calling on various locations, including destinations in Scandinavia, Russia, the Mediterranean, the Greek Isles, Alaska, Canada and New England, Hawaii, Asia, Tahiti and the South Pacific, Australia and New Zealand, Africa, India, South America, the Panama Canal, and the Caribbean. As of December 31, 2021, the company had 28 ships with approximately 59,150 berths. It distributes its products through retail/travel advisor and onboard cruise sales channels, as well as meetings, incentives, and charters. Norwegian Cruise Line Holdings Ltd. was founded in 1966 and is based in Miami, Florida.
NASDAQ ended the session with Norwegian Cruise Line falling 9.94% to $14.86 on Tuesday while NASDAQ dropped 0.1% to $11,455.54.
Norwegian cruise line (nclh) reports Q4 loss, tops revenue estimatesWhile Norwegian Cruise Line has outperformed the market so far this year, the question that comes to investors’ minds is: what’s next for the stock?
Earnings Per Share
As for profitability, Norwegian Cruise Line has a trailing twelve months EPS of $-15.75.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -204.7%.
Moving Average
Norwegian Cruise Line’s value is under its 50-day moving average of $15.13 and higher than its 200-day moving average of $14.39.
More news about Norwegian Cruise Line.
2. MIND Technology (MIND) – -9.49%
MIND Technology, Inc., together with its subsidiaries, provides technology to the oceanographic, hydrographic, defense, seismic and maritime security industries. It develops, manufactures, and sells proprietary products. The company's products include the GunLink seismic source acquisition and control systems that provide operators of marine seismic surveys with precise monitoring and control of energy sources; the BuoyLink RGPS tracking system, which is used to offer precise positioning of marine seismic energy sources and streamers; Digishot energy source controllers; Sleeve Gun energy sources; and SeaLink product line of marine sensors and solid streamer systems. It also provides streamer weight collars, depth and pressure transducers, air control valves, and source array systems; spare and replacement parts; and repair and engineering services, training and field service operations, and umbilical terminations, as well as side scan sonar systems and related products. The company markets its products to governmental and commercial customers through internal sales organization and a network of distributors and representatives. It serves in in the United States, Europe, Russia, CIS, the Middle East, Africa, the Asia-Pacific, Canada, and Latin America. The company was formerly known as Mitcham Industries, Inc. MIND Technology, Inc. was incorporated in 1987 and is headquartered in The Woodlands, Texas.
NASDAQ ended the session with MIND Technology sliding 9.49% to $0.53 on Tuesday, following the last session’s downward trend. NASDAQ fell 0.1% to $11,455.54, after two successive sessions in a row of losses, on what was a somewhat down trend exchanging session today.
Earnings Per Share
As for profitability, MIND Technology has a trailing twelve months EPS of $-1.804.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -54.91%.
Moving Average
MIND Technology’s value is under its 50-day moving average of $0.55 and way below its 200-day moving average of $0.69.
Yearly Top and Bottom Value
MIND Technology’s stock is valued at $0.53 at 16:32 EST, way below its 52-week high of $1.53 and way above its 52-week low of $0.37.
Sales Growth
MIND Technology’s sales growth for the current quarter is 219.2%.
Volume
Today’s last reported volume for MIND Technology is 22746 which is 72.34% below its average volume of 82235.
More news about MIND Technology.
3. Atrion (ATRI) – -8.96%
Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Canada, Europe, and internationally. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. The company's cardiovascular products comprise Myocardial Protection System that delivers fluids and medications and mixes critical drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. Its ophthalmic products include specialized medical devices that disinfect contact lenses; and a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. The company also manufactures instrumentation and associated disposables that measure the activated clotting time of blood; and products for safe needle and scalpel blade containment. In addition, it manufactures inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; and one-way and two-way pressure relief valves that protect sensitive electronics and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales force, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.
NASDAQ ended the session with Atrion falling 8.96% to $594.15 on Tuesday, following the last session’s downward trend. NASDAQ dropped 0.1% to $11,455.54, after two successive sessions in a row of losses, on what was a somewhat bearish trend trading session today.
Earnings Per Share
As for profitability, Atrion has a trailing twelve months EPS of $17.44.
PE Ratio
Atrion has a trailing twelve months price to earnings ratio of 34.07. Meaning, the purchaser of the share is investing $34.07 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.34%.
Yearly Top and Bottom Value
Atrion’s stock is valued at $594.15 at 16:32 EST, way under its 52-week high of $783.80 and way above its 52-week low of $534.99.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Atrion’s stock is considered to be overbought (>=80).
Revenue Growth
Year-on-year quarterly revenue growth grew by 4.1%, now sitting on 180.94M for the twelve trailing months.
More news about Atrion.
4. Magic Software Enterprises Ltd. (MGIC) – -7.36%
Magic Software Enterprises Ltd. provides proprietary application development, business process integration, vertical software solutions, and information technologies (IT) outsourcing software services in Israel and internationally. The company's Software Services segment develops, markets, sells, and supports application platform, software applications, and business and process integration solutions and related services. Its IT Professional Services segment offers IT services in the areas of infrastructure design and delivery, application development, technology planning and implementation services, communications services and solutions, and supplemental outsourcing services. The company offers proprietary application platforms, such as Magic xpa for developing and deploying business applications; AppBuilder for building, deploying, and maintaining high-end and mainframe-grade business applications; Magic xpi for application integration; Magic xpc, a hybrid integration platform as a service; Magic SmartUX, a mobile development application platform; and FactoryEye for virtualization of production data. It also provides vertical software solutions comprising Clicks, a software solution for healthcare providers; Leap, a software solution for business support systems; Hermes Solution, a packaged software solution for managing air cargo ground handling; HR Pulse, a customized single-tenant software as a service tool; and MBS Solution, a proprietary system for managing TV broadcast management. In addition, the company provides software maintenance, support, training, and consulting services. It serves oil and gas, telecommunications, financial, healthcare, and industrial sectors; and public institutions and international agencies. The company was formerly known as Mashov Software Export (1983) Ltd. and changed its name to Magic Software Enterprises Ltd. in 1991. Magic Software Enterprises Ltd. was incorporated in 1983 and is headquartered in Or Yehuda, Israel.
NASDAQ ended the session with Magic Software Enterprises Ltd. dropping 7.36% to $13.59 on Tuesday, after two consecutive sessions in a row of losses. NASDAQ fell 0.1% to $11,455.54, after two consecutive sessions in a row of losses, on what was a somewhat down trend trading session today.
Earnings Per Share
As for profitability, Magic Software Enterprises Ltd. has a trailing twelve months EPS of $0.64.
PE Ratio
Magic Software Enterprises Ltd. has a trailing twelve months price to earnings ratio of 21.23. Meaning, the purchaser of the share is investing $21.23 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.8%.
Moving Average
Magic Software Enterprises Ltd.’s worth is way under its 50-day moving average of $16.15 and way below its 200-day moving average of $16.82.
More news about Magic Software Enterprises Ltd..
5. Kosmos Energy (KOS) – -7.31%
Kosmos Energy Ltd., a deep-water independent oil and gas exploration and production company, focuses along the Atlantic Margins. The company's primary assets include production offshore Ghana, Equatorial Guinea, and the U.S. Gulf of Mexico, as well as a gas development offshore Mauritania and Senegal. It also maintains a proven basin exploration program. The company was founded in 2003 and is headquartered in Dallas, Texas.
NYSE ended the session with Kosmos Energy dropping 7.31% to $7.93 on Tuesday, after three sequential sessions in a row of gains. NYSE fell 0.24% to $15,456.35, after two consecutive sessions in a row of losses, on what was a somewhat down trend trading session today.
Earnings Per Share
As for profitability, Kosmos Energy has a trailing twelve months EPS of $-1.02.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 74.48%.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is a negative 7.7% and a negative 30%, respectively.
More news about Kosmos Energy.
6. Nektar Therapeutics (NKTR) – -6.71%
Nektar Therapeutics operates as a biopharmaceutical company. The company researches and develops pipeline of investigational medicines in oncology, immunology, and virology, as well as a portfolio of approved partnered medicines. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, renal cell carcinoma, muscle-invasive bladder cancer, and adjuvant melanoma; phase 2 clinical trial for the treatment of renal cell carcinoma and urothelial cancer; phase 1/2A clinical trial to treat squamous cell carcinoma of the head and neck; phase 1/2 clinical trial for the treatment of non-small cell lung cancer and immuno-oncology; and phase 1B clinical trial to treat COVID-19.It is also developing NKTR-358, a cytokine Treg stimulant that is in phase 2 clinical trial for the treatment of systemic lupus erythematosus and ulcerative colitis, as well as phase 1B clinical trial to treat atopic dermatitis and psoriasis; NKTR-255, an IL-15 receptor agonist, which is in phase 2 clinical trial for the treatment of non-Hodgkin's lymphoma and multiple myeloma, and head and neck cancer and colorectal cancer; and NKTR-262, a toll-like receptor agonist that is in phase 1/2 clinical trial to treat locally advanced or metastatic solid tumor malignancies, as well as various other drug candidates. The company has collaboration agreements with Takeda Pharmaceutical Company Ltd.; AstraZeneca AB; UCB Pharma S.A.; F. Hoffmann-La Roche Ltd; Bausch Health Companies Inc.; Pfizer Inc.; Amgen Inc.; UCB Pharma (Biogen); Bristol-Myers Squibb Company; Baxalta Incorporated; Eli Lilly and Company; Merck; and SFJ Pharmaceuticals, Inc. Nektar Therapeutics was incorporated in 1990 and is headquartered in San Francisco, California with additional operations in Huntsville, Alabama and Hyderabad, India.
NASDAQ ended the session with Nektar Therapeutics falling 6.71% to $1.39 on Tuesday, after two consecutive sessions in a row of losses. NASDAQ fell 0.1% to $11,455.54, after two sequential sessions in a row of losses, on what was a somewhat bearish trend exchanging session today.
Earnings Per Share
As for profitability, Nektar Therapeutics has a trailing twelve months EPS of $-2.49.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -74.83%.
Yearly Top and Bottom Value
Nektar Therapeutics’s stock is valued at $1.39 at 16:32 EST, way under its 52-week high of $11.39 and higher than its 52-week low of $1.38.
More news about Nektar Therapeutics.
7. DISH Network (DISH) – -6.68%
DISH Network Corporation, together with its subsidiaries, provides pay-TV services in the United States. The company operates in two segments, Pay-TV and Wireless. It offers video services under the DISH TV brand; and programming packages that include programming through national broadcast networks, local broadcast networks, and national and regional cable networks, as well as regional and specialty sports channels, premium movie channels, and Latino and international programming packages. The company also provides access to movies and television shows through TV or Internet-connected devices; and dishanywhere.com and mobile applications on Internet-connected devices to view authorized content, search program listings, and remotely control certain features of their DVRs. In addition, it offers Sling TV services, including Sling domestic, Sling International, Sling Latino, Sling Orange, and Sling Blue services that require an Internet connection and are available on streaming-capable devices, such as streaming media devices, TVs, tablets, computers, game consoles, and phones, as well as market SLING TV services to consumers who do not subscribe to traditional satellite and cable pay-TV services. Further, the company provides wireless subscribers consumer plans with no annual service contracts, as well as monthly service plans, including high-speed data and unlimited talk and text. As of December 31, 2021, it had 10.707 million pay-TV subscribers in the United States, including 8.221 million DISH TV subscribers and 2.486 million SLING TV subscribers. The company offers receiver systems and programming through direct sales channels, as well as independent third parties, such as small retailers, direct marketing groups, local and regional consumer electronics stores, retailers, and telecommunications companies. DISH Network Corporation was founded in 1980 and is headquartered in Englewood, Colorado.
NASDAQ ended the session with DISH Network dropping 6.68% to $11.39 on Tuesday, after two successive sessions in a row of losses. NASDAQ fell 0.1% to $11,455.54, after two successive sessions in a row of losses, on what was a somewhat bearish trend exchanging session today.
Earnings Per Share
As for profitability, DISH Network has a trailing twelve months EPS of $3.88.
PE Ratio
DISH Network has a trailing twelve months price to earnings ratio of 2.94. Meaning, the purchaser of the share is investing $2.94 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.11%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 8%, now sitting on 17.08B for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, DISH Network’s stock is considered to be overbought (>=80).
More news about DISH Network.
8. Nymox Pharmaceutical Corporation (NYMX) – -6.58%
Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population in Canada, the United States, Europe, and internationally. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which has completed Phase III clinical trials for the treatment of benign prostatic hyperplasia, and Phase II clinical trials for low grade localized prostate cancer, as well as is in preclinical studies for hepatocellular carcinoma. The company also develops and markets NicAlert and TobacAlert tests that use urine or saliva to detect use of tobacco products. In addition, it offers AlzheimAlert, a proprietary urine assay that aids physicians in the diagnosis of Alzheimer's disease, as well as researches and develops drug treatments for Alzheimer's disease. The company was founded in 1989 and is headquartered in Nassau, the Bahamas.
NASDAQ ended the session with Nymox Pharmaceutical Corporation dropping 6.58% to $0.37 on Tuesday while NASDAQ fell 0.1% to $11,455.54.
Earnings Per Share
As for profitability, Nymox Pharmaceutical Corporation has a trailing twelve months EPS of $-0.08.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -683.11%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Nymox Pharmaceutical Corporation’s EBITDA is -23.99.
Yearly Top and Bottom Value
Nymox Pharmaceutical Corporation’s stock is valued at $0.37 at 16:32 EST, way below its 52-week high of $2.10 and way above its 52-week low of $0.19.
More news about Nymox Pharmaceutical Corporation.
9. Peoples Financial Corporation (PFBX) – -6.56%
Peoples Financial Corporation operates as the bank holding company for The Peoples Bank that provides banking, financial, and trust services to government entities, individuals, and small and commercial businesses in Mississippi. It accepts various deposits, such as interest and non-interest bearing checking accounts, savings accounts, certificates of deposit, and individual retirement accounts (IRAs). The company also offers business, commercial, real estate, construction, personal, and installment loans; and personal trust, agencies, and estate services, including living and testamentary trusts, executorships, guardianships, and conservatorships. In addition, it provides self-directed IRAs; and escrow management, stock transfer, and bond paying agency accounts to corporate customers. Further, the company offers various other services consisting of safe deposit box rental, wire transfer, night drop facilities, collection, cash management, and internet banking services. As of December 31, 2021, the company operated through 17 branches located in Harrison, Hancock, Jackson, and Stone counties. It also has 28 automated teller machines at its branch locations, as well as other off-site and non-proprietary locations. The company was founded in 1896 and is headquartered in Biloxi, Mississippi.
NASDAQ ended the session with Peoples Financial Corporation dropping 6.56% to $14.25 on Tuesday, following the last session’s upward trend. NASDAQ slid 0.1% to $11,455.54, after two sequential sessions in a row of losses, on what was a somewhat negative trend exchanging session today.
Earnings Per Share
As for profitability, Peoples Financial Corporation has a trailing twelve months EPS of $1.91.
PE Ratio
Peoples Financial Corporation has a trailing twelve months price to earnings ratio of 7.46. Meaning, the purchaser of the share is investing $7.46 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.84%.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Nov 3, 2022, the estimated forward annual dividend rate is 0.19 and the estimated forward annual dividend yield is 1.25%.
Moving Average
Peoples Financial Corporation’s worth is below its 50-day moving average of $14.52 and under its 200-day moving average of $15.34.
More news about Peoples Financial Corporation.
10. DouYu (DOYU) – -6.06%
DouYu International Holdings Limited, together with its subsidiaries, operates a platform on PC and mobile apps that provides interactive games and entertainment live streaming services in the People's Republic of China. Its platform connects game developers and publishers, professional eSports teams or players and eSports tournament organizers, advertisers, and viewers. The company also sponsors eSports teams and organizes eSports tournaments. In addition, it streams other content to include a spectrum of live streaming entertainment options, such as talent shows, music, outdoor, and travel. Further, the company records and offers video clips to allow users to watch replays of selective live streaming content; and allows viewers and streamers to edit and upload short video clips by themselves. DouYu International Holdings Limited was founded in 2014 and is headquartered in Wuhan, the People's Republic of China.
NASDAQ ended the session with DouYu sliding 6.06% to $1.24 on Tuesday, after five consecutive sessions in a row of losses. NASDAQ slid 0.1% to $11,455.54, after two successive sessions in a row of losses, on what was a somewhat negative trend trading session today.
Earnings Per Share
As for profitability, DouYu has a trailing twelve months EPS of $-0.255.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -4.93%.
Sales Growth
DouYu’s sales growth is negative 19.7% for the ongoing quarter and 2.9% for the next.
Moving Average
DouYu’s worth is way under its 50-day moving average of $1.58 and below its 200-day moving average of $1.31.
Volume
Today’s last reported volume for DouYu is 1003540 which is 35.88% below its average volume of 1565240.
Revenue Growth
Year-on-year quarterly revenue growth declined by 23.4%, now sitting on 7.76B for the twelve trailing months.
More news about DouYu.
Stay up to date with our winners and losers daily report
